VIVUS Announces Date of 2017 First Quarter Busines
Post# of 617763
CAMPBELL, CA --(Marketwired - April 25, 2017) - VIVUS, Inc. (
Date: May 3, 2017 Time: 4:30 PM ET
Listen via Internet: http://ir.vivus.com/
Webcast Link: http://edge.media-server.com/m/p/76esnfqz
Dial in (Toll-Free): (877) 359-2916 Dial in (International): (224) 357-2386 Audience Passcode: 938 46 816
A webcast replay will be available on the VIVUS website for 30 days.
VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet medical needs in human health. For more information about the company, please visit www.vivus.com .
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ended December 31, 2016 as filed on March 8, 2017 and periodic reports filed with the Securities and Exchange Commission.
CONTACT: VIVUS, Inc. Mark Oki Chief Financial Officer 650-934-5268 oki@vivus.com The Trout Group Brian Korb Managing Director 646-378-2923 bkorb@troutgroup.com